hotspot -WSS

hotspot

author：explore 2025-09-29 01:36:48 - browse：69

Person wearing a smart watch. -- first opinion coverage from STAT — Adobe

The Apple Watch has secured a new qualification from the Food and Drug Administration that could make the smartwatch an appealing tool for medical device companies hoping to illustrate the benefits of a common heart procedure.

Last week, the Apple Watch’s Atrial Fibrillation History feature became the first digital tool qualified under the Medical Device Development Tools (MDDT) program. Released in 2022, the feature estimates a user’s A-fib burden, or how much time they spend in atrial fibrillation, which is an irregular heart rhythm that can cause shortness of breath and fatigue, and is also linked to an increased risk of stroke.

The qualification means that FDA has determined in advance that sponsors can use the feature as a secondary endpoint in clinical trials without having to do additional work. Specifically, the Apple Watch is qualified for use as a secondary endpoint in clinical trials for cardiac ablation devices, which reduce the electrical signals that cause A-fib by scarring the heart with extreme heat or cold energy. Pulsed field ablation is the latest version of the technology, using a controlled electric field to scar tissue rather than the riskier thermal energy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Van's Gluten Free Original Waffles recalled for possible wheat allergen

focus

hotspot

WSS

Medicare inequities exacerbate Puerto Rico’s health disparities

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Van's Gluten Free Original Waffles recalled for possible wheat allergen

Meta looks to target Twitter with a rival app called Threads

NIH study of ME/CFS points to clear biological hallmarks

6 phony surgeries that take placebo to the extreme

entertainment

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Wikipedia

Apple is now the first public company to be valued at $3 trillion

Listen: Biogen's messy board & Laronde's data problem

Peter Hotez and the public health issue of online harassment

R1 RCM gets $5.8 billion buyout offer from private equity firm

Moonlake's readout produced a cash windfall. Risks remain

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

What does generative AI mean for health care? We asked experts

The Harvard botanist who searched for psychedelics in the Amazon

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Community addresses injustice for Long Island mothers

Wikipedia

Grail is spending more than ever lobbying Congress

Community Health Systems hospitals under DOJ investigation

Can food be medicine? And other questions about a new push

Make 'food is medicine' a key part of White House nutrition meeting

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

A new study asks: Are we harming blood donors by taking blood?

hotspot

focus

hotspot

Wikipedia